KLIMIK JOURNAL, vol.31, no.1, pp.16-19, 2018 (ESCI)
Objective: Chronic hepatitis is a common cause of liver-related morbidity due to hepatotropic viruses, such as hepatitis B virus (HBV) and hepatitis C virus (HCV). HBV/HCV co-infection leads to more severe liver diseases and increased risk of hepatocellular carcinoma. In addition, hepatitis B virus reactivation has been reported after treatment for chronic hepatitis C in patients with HBV/HCV co-infection. In our study, we aimed to detect the prevalence of HBV/HCV co-infection in anti-HCV-positive samples, retrospectively.